31-45 of 235
Off-Label Medicines in Fighting COVID-19 & Through the Years
COVID-19: On The FrontlinesOff-Label Medicines in Fighting COVID-19 & Through the Years
Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
The Drug ReportUncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
The Drug ReportA Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
REMS-Required Drug Monitoring During the COVID-19 Pandemic
The Drug ReportREMS-Required Drug Monitoring During the COVID-19 Pandemic
CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
The Drug ReportCDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
COVID-19 & the Potential for Prescription Drug Shortages
Public Health On CallCOVID-19 & the Potential for Prescription Drug Shortages
- advertisement
Update on Remdesivir, Investigational Antiviral for COVID-19
The Drug ReportUpdate on Remdesivir, Investigational Antiviral for COVID-19
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
COVID-19: On The FrontlinesChloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
AudioAbstractsReal-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
Bottles of Lies: The Inside Story of the Generic Drug Boom
Book ClubBottles of Lies: The Inside Story of the Generic Drug Boom
Delirium: The Hidden Disorder Plaguing ICU Patients
Clinician's RoundtableDelirium: The Hidden Disorder Plaguing ICU Patients
Facts, Myths, & Misconceptions of Medical Marijuana
Conference CoverageFacts, Myths, & Misconceptions of Medical Marijuana
- advertisement
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA Drug Information UpdatesFDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
Book ClubThe Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Project Oncology®FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
